Skip to content

H.R. 5385 · 118th Congress (2023–2025)

Medicare PBM Accountability Act

This bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.

Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.

In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.

Show official title

To amend title XVIII of the Social Security Act to establish pharmacy benefit manager reporting requirements with respect to prescription drug plans and MA-PD plans under Medicare part D.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 5385’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Greg Landsman (D-OH-1)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Rep. Diana Harshbarger (R-TN-1)· Original · Sep 12, 2023
Policy area
Health
Subjects
  • Accounting and auditing
  • Congressional oversight
  • Contracts and agency
  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Government studies and investigations
  • Health care costs and insurance
  • Prescription drugs
  • 1 more
    • Retail and wholesale trades

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 8 committee actions · Sep 12, 2023 – Dec 17, 2024
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
    3. Subcommittee markup session held

      Subcommittee Consideration and Mark-up Session Held

      Sources
    4. Forwarded by subcommittee

      Forwarded by Subcommittee to Full Committee by Voice Vote.

      Sources
    5. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    6. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    7. Ordered reported

      Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.

      Sources
    8. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Sep 12, 2023 · Markup Dec 5, 2023 · Markup Dec 6, 2023
    1. Dec 5, 2023 · Markup

  2. HouseHealthReferred Sep 15, 2023 · Markup Nov 15, 2023 · Reported Nov 15, 2023
    1. Nov 15, 2023 · Meeting

    2. Sep 19, 2023 · Meeting

  3. HouseWays and MeansReferred Sep 12, 2023
  4. HouseHealthReferred Dec 17, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Medicare PBM Accountability Act

    Display title, Short title · Introduced in House

  2. To amend title XVIII of the Social Security Act to establish pharmacy benefit manager reporting requirements with respect to prescription drug plans and MA-PD plans under Medicare part D.

    Official title · Introduced in House